Although the causative role of aberrant glutamate uptake in these diseases is not always supported by published data, downregulation of GLAST and GLT-1 expression has been correlated with cognitive deficits associated with the diseases mentioned before [130]. The gene discussed is SLC1A3; the disease is Cognitive impairment.